AMD to Report Fiscal Second Quarter 2025 Financial Results
AMD also announced it will participate in the following event for the financial community:
Jean Hu, executive vice president, chief financial officer and treasurer, will present at Citi's 2025 Global TMT Conference on Wednesday, Sept. 3, 2025.
A webcast of the presentations can be accessed on AMD's Investor Relations website ir.amd.com.
About AMD For more than 55 years AMD has driven innovation in high-performance computing, graphics and visualization technologies. Billions of people, leading Fortune 500 businesses and cutting-edge scientific research institutions around the world rely on AMD technology daily to improve how they live, work and play. AMD employees are focused on building leadership high-performance and adaptive products that push the boundaries of what is possible. For more information about how AMD is enabling today and inspiring tomorrow, visit the AMD (NASDAQ: AMD) website, blog, LinkedIn, Facebook and X pages.ContactPhil HughesAMD Communications512-865-9697 phil.hughes@amd.com
Liz StineAMD Investor Relations(720) 652-3965liz.stine@amd.comSign in to access your portfolio
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
an hour ago
- Yahoo
Cogent Biosciences Announces Pricing of Upsized Public Offering of Shares of Common Stock
WALTHAM, Mass. and BOULDER, Colo., July 08, 2025 (GLOBE NEWSWIRE) -- Cogent Biosciences, Inc. (Nasdaq: COGT), a biotechnology company focused on developing precision therapies for genetically defined diseases, today announced the pricing of its previously announced underwritten public offering of 22,222,223 shares of its common stock, offered at a public offering price of $9.00 per share. The aggregate gross proceeds to Cogent from this offering are expected to be approximately $200 million, before deducting underwriting discounts and commissions and other offering expenses. In addition, Cogent has granted the underwriters a 30-day option to purchase up to an additional 3,333,333 shares of its common stock on the same terms and conditions. All of the securities in the offering are being sold by Cogent. The offering is expected to close on or about July 10, 2025, subject to the satisfaction of customary closing conditions. Cogent intends to use the net proceeds from the offering for continued development, regulatory and commercial preparation activities relating to bezuclastinib and other product candidates, activities to support the planned commercial launch of bezuclastinib as well as for working capital and general corporate purposes. J.P. Morgan, Leerink Partners and Guggenheim Securities are acting as joint book-running managers for the offering. LifeSci Capital is also acting as lead manager for the offering. The securities described above are being offered pursuant to an automatic shelf registration statement on Form S-3ASR (File No. 333-269707), which was filed with the Securities and Exchange Commission (SEC) on February 10, 2023 and automatically became effective upon filing. A preliminary prospectus supplement and accompanying base prospectus relating to and describing the terms of the offering were filed with the SEC on July 8, 2025. A final prospectus supplement and the accompanying base prospectus relating to and describing the terms of the offering will be filed with the SEC. The securities described above have not been qualified under any state blue sky laws. This press release shall not constitute an offer to sell or the solicitation of an offer to buy these securities, nor shall there be any sale of these securities in any state or jurisdiction in which such offer, solicitation or sale would be unlawful prior to the registration or qualification under the securities laws of any such state or jurisdiction. The offering can be made only by means of a prospectus supplement and accompanying base prospectus, copies of which may be obtained at the SEC's website at or by request to J.P. Morgan Securities LLC, c/o Broadridge Financial Solutions, 1155 Long Island Avenue, Edgewood, NY 11717, or by email at prospectus-eq_fi@ and postsalemanualrequests@ Leerink Partners LLC, Attention: Syndicate Department, 53 State Street, 40th Floor, Boston, MA 02109, by telephone at (800) 808-7525, ext. 6105, or by email at syndicate@ or Guggenheim Securities, LLC, Attention: Equity Syndicate Department, 330 Madison Ave., New York, NY 10017, or by telephone at (212) 518-9544, or by email at GSEquityProspectusDelivery@ About Cogent Biosciences, Inc. Cogent Biosciences is a biotechnology company focused on developing precision therapies for genetically defined diseases. The most advanced clinical program, bezuclastinib, is a selective tyrosine kinase inhibitor that is designed to potently inhibit the KIT D816V mutation as well as other mutations in KIT exon 17. KIT D816V is responsible for driving systemic mastocytosis, a serious disease caused by unchecked proliferation of mast cells. Exon 17 mutations are also found in patients with advanced gastrointestinal stromal tumors, a type of cancer with strong dependence on oncogenic KIT signaling. The company also has an ongoing Phase 1 study of its novel internally discovered FGFR2 inhibitor. In addition, the Cogent Research Team is developing a portfolio of novel targeted therapies to help patients fighting serious, genetically driven diseases targeting mutations in ErbB2, PI3Kα and KRAS. Cogent Biosciences is based in Waltham, MA and Boulder, CO. Forward-looking Statements This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. All statements, other than statements of historical facts, contained in this press release, including statements regarding the completion of the public offering and the use of proceeds therefrom, are forward-looking statements. The use of words such as, but not limited to, 'anticipate,' 'believe,' 'continue,' 'could,' 'estimate,' 'expect,' 'intend,' 'may,' 'might,' 'plan,' 'potential,' 'predict,' 'project,' 'should,' 'target,' 'will,' or 'would' and similar words or expressions are intended to identify forward-looking statements. Forward-looking statements are neither historical facts nor assurances of future performance. Instead, they are based on our current beliefs, expectations and assumptions regarding the future of our business, future plans and strategies, our clinical results, the rate of enrollment in our clinical trials and other future conditions. New risks and uncertainties may emerge from time to time, and it is not possible to predict all risks and uncertainties. No representations or warranties (expressed or implied) are made about the accuracy of any such forward-looking statements. We may not actually achieve the forecasts or milestones disclosed in our forward-looking statements, and you should not place undue reliance on our forward-looking statements. Such forward-looking statements are subject to a number of material risks and uncertainties including but not limited to our capital position and the sufficiency of our capital to fund our operations in future periods; our use of the net proceeds of the underwritten public offering; risks and uncertainties related to market conditions and the satisfaction of customary closing conditions related to the underwritten public offering; the impact of general economic, health, industrial or political conditions in the United States or internationally; and other risks and uncertainties identified in our filings with the SEC, including our Registration Statement on Form S-3ASR, which was filed with the SEC on February 10, 2023 and automatically became effective upon filing, as may be amended from time to time, together with the accompanying base prospectus contained therein and the documents incorporated by reference therein, including our most recent Annual Report on Form 10-K, our Quarterly Report on Form 10-Q and our subsequent periodic reports filed with the SEC, and the preliminary prospectus supplement related to this offering. Any forward-looking statement speaks only as of the date on which it was made. Neither we, nor our affiliates, advisors or representatives, undertake any obligation to publicly update or revise any forward-looking statement, whether as result of new information, future events or otherwise, except as required by law. These forward-looking statements should not be relied upon as representing our views as of any date subsequent to the date hereof. Contact: Christi WaarichSenior Director, Investor
Business Upturn
3 hours ago
- Business Upturn
Zig-Zag Launches New Premium Natural Leaf Cigar Line – Zig-Zag Woods
By GlobeNewswire Published on July 9, 2025, 02:53 IST Los Angeles, California, July 08, 2025 (GLOBE NEWSWIRE) — Zig-Zag Launches New Premium Natural Leaf Cigar Line – Zig-Zag Woods Slow-Burning, Boldly Flavored, and Value-Priced for High Turnover in Convenience and Smoke Shop Channels Zig-Zag, a heritage brand trusted by millions, proudly announces the launch of Zig-Zag Woods, a new line of premium natural leaf cigars crafted for today's adult cigar consumer and strategically designed for convenience stores and smoke shops. With more than 58% of consumers referring to rough-cut cigars as 'woods', this launch meets consumer expectations with a name and format that resonates. Zig-Zag Woods features a slow-burning, all-natural leaf wrap filled with premium rough-cut tobacco, delivering a rich and smooth smoking experience. With bold flavor profiles and recognizable Zig-Zag branding, this line is engineered for fast sell-through and high margins. Over 300 million rough-cut cigars are sold annually (MSA), demonstrating the strength of this segment, and Zig-Zag Woods is primed to compete and win. Product Offering: 5 Varieties: Natural Silk & Berries Sweet Aromatic Crème Royale Velvet Pre-Priced: $1.39 for 2 cigars $1.39 for 2 cigars Packaging Configuration: 15 pouches per carton 24 cartons per case Whether your customers prefer the boldness of Sweet Aromatic or the smoothness of Velvet, Zig-Zag Woods provides a flavor for every taste. With its competitive price point, premium quality, and shelf-ready format, Zig-Zag Woods is primed to become a top seller in the natural leaf cigar segment. 'Customers have been asking for a premium value-added product that moves quickly and satisfies customers. Zig-Zag Woods is our answer,' said Jessica Chesney, SBM of Marketing at Zig-Zag. 'We've combined quality, flavor variety, and value into a package that's a win for both consumers and the trade.' Now Shipping Nationwide Zig-Zag Woods are now available for wholesale and retail ordering. For more information, promotional assets, or to place an order, contact Zig-Zag customer service at (800) 331-5962 [email protected] or visit TPB Marketplace. About Zig-Zag Zig-Zag is a market leader in premium tobacco and smoking accessories, known for its authenticity, innovation, and quality. With a legacy spanning over 140 years, Zig-Zag continues to evolve with consumer trends while delivering reliable products to its retail partners. Zig-Zag is exclusively distributed by Turning Point Brands (NYSE: TPB), a manufacturer, marketer, and distributor of branded consumer products. Attachment Zig-Zag Launches New Premium Natural Leaf Cigar Line – Zig-Zag Woods Disclaimer: The above press release comes to you under an arrangement with GlobeNewswire. Business Upturn takes no editorial responsibility for the same. Ahmedabad Plane Crash GlobeNewswire provides press release distribution services globally, with substantial operations in North America and Europe.
Business Upturn
3 hours ago
- Business Upturn
K92 Mining Announces Strong Q2 Production Results – 34,816 oz AuEq Produced, and Commenced Commissioning of 1.2 Mtpa Stage 3 Process Plant in June
By GlobeNewswire Published on July 9, 2025, 02:00 IST VANCOUVER, British Columbia, July 08, 2025 (GLOBE NEWSWIRE) — K92 Mining Inc. ('K92' or the 'Company') (TSX: KNT; OTCQX: KNTNF) is pleased to announce production results for the second quarter ('Q2') of 2025 from its Kainantu Gold Mine in Papua New Guinea. Q2 2025 Production Results Strong quarterly production of 34,816 ounces gold equivalent ('AuEq') (1) or 32,375 oz gold, 1,536,505 lbs copper and 42,824 oz silver, representing a 43% increase from Q2 2024. Quarterly sales of 28,864 oz gold, 1,275,176 lbs copper and 34,532 oz silver. With 82,633 oz AuEq produced during the first six months of 2025, which is ahead of budget, and the second half forecasted to be the strongest, as outlined in our 2025 Operational Outlook (see January 23, 2025 press release ), the Company re-iterates its annual operational production guidance of 160,000 to 185,000 oz AuEq. Quarterly ore processed of 130,337 tonnes, a 36% and 26% increase from Q2 2024 and Q1 2025, respectively, with a head grade of 8.9 grams per tonne ('g/t') AuEq, or 8.3 g/t gold, 0.55% copper and 12.1 g/t silver. Strong metallurgical recoveries in Q2 of 93.3% for gold and 94.9% for copper. The process plant has now delivered four consecutive quarters exceeding the updated definitive feasibility study ('Updated DFS') recovery parameters for both gold (92.6%) and copper (94.2%) (January 1, 2024 effective date). Ore mined of 133,063 tonnes, with mining activity across 13 levels, including the 1090, 1110, 1305, 1325, 1345, and 1365 levels at Kora, and the 970, 990, 1170, 1325, 1345, 1365 and 1385 levels at Judd – long hole open stoping performed to design. Total material movements (ore plus waste) totaled 338,696 tonnes and total mine development was 2,466 metres. During the quarter, total material movements were the second highest on record, even though Stage 3 Expansion electrical commissioning works resulted in a cumulative 5 days of disruptions to the underground, which has largely been resolved. Stage 3 Expansion – Significant Progress Made. Stage 3 Plant Commissioning Commenced. Major milestone achieved in the second half of June, with the commencement of commissioning of the new 1.2 million tonnes-per-annum Stage 3 Expansion Process Plant. All pre-commissioning tasks have been completed, and inching of both the SAG and ball mills was completed in late June. Practical completion of commissioning remains on schedule for the first half of Q4 2025. In June, the Engineering, Procurement, and Construction Management (EPCM) contract for the pastefill filtration plant and the Engineering, Procurement, and Construction (EPC) contract for the surface storage facility packages were awarded, with the underground pastefill plant package self-awarded earlier in the quarter. Commissioning of all three facilities is scheduled to commence in mid-Q1 2026, while practical completion of commissioning for the pastefill circuit remains on schedule for mid-2026. As at June 30, 2025, 86% of Stage 3 Expansion growth capital has either been spent or committed (75% as at March 31, 2025) and remains on budget. In Q2, several ancillary construction projects were completed, including: i) the temporary power station; ii) Phase 1 of the permanent power station, and; iii) the Kumian Creek camp accommodation facilities. The 160 ensuite room Kumian Creek Camp is initially being utilized for construction contractors, then will subsequently be utilized for the Stage 4 Expansion. The infrastructure-driven transformation of the underground mine is nearly complete for the Stage 3 Expansion, with various underground construction projects well advanced and scheduled for completion in Q3, including: i) a fully operational ore/waste pass, ii) Puma ventilation drive; and iii) two additional raisebore ventilation raises. In June, the wifi/fibre optic communications upgrade was completed, enabling the introduction of various productivity technologies, with the first being the commissioning of surface operated tele-remote loaders, which commenced in June. Two new mining fronts have also been significantly developed, including 4 new sublevels in the Twin Incline mining front and 2 new sublevels in the Lower Kora mining front, with stoping planned to commence in Q4. Note (1): Gold equivalent production for Q2 2025 is calculated based on: gold $3,299 per ounce; silver $33.41 per ounce; and copper $4.31 per pound. Gold equivalent grade for Q2 incorporates realized recoveries of 93.3% for Au, 94.9% for Cu and 83.7% for Ag. John Lewins, K92 Chief Executive Officer and Director, stated, 'K92 is on the cusp of transforming into a Tier 1 mid-tier producer, with commissioning of the new 1.2 million tonnes-per-annum Stage 3 Expansion Process Plant now underway. The plant incorporates state-of-the-art processing technologies and remains on schedule for practical completion of commissioning in the first half of Q4 2025. Underground infrastructure upgrades are also nearing completion, including a fully operational ore/waste pass, Puma ventilation drive, and two large-diameter raisebore ventilation raises — key enablers for higher mining rates. Additionally, the recent commencement of commissioning surface-operated tele-remote loaders marks the first wave of productivity enhancements enabled by our underground communications upgrade. Importantly, we are also well-advanced on opening up two new mining fronts in the Twin Incline and the Lower Kora, which position the mine for higher throughput and an increase in ore tonnes from lower-cost long-hole stoping. Meanwhile, construction contracts for all major pastefill infrastructure have been awarded, with commissioning expected to commence in mid-Q1 2026. Overall we are very pleased with our production performance in the first half of 2025, which is ahead of budget. With a stronger second half anticipated, driven by higher throughput in Q4, we reiterate our 2025 production guidance.' See Figure 1: Quarterly Production, Cash Cost and AISC Chart See Figure 2: Gold and Copper Recoveries Chart Table 1 – 2025 & 2024 Annual Production Data Q2 2024 Q3 2024 Q4 2024 2024 Q1 2025 Q2 2025 Tonnes Processed T 95,582 104,992 96,614 427,821 103,449 130,337 Feed Grade Au g/t 7.5 13.0 17.3 10.7 14.3 8.3 Feed Grade Cu % 0.62% 0.58% 0.47% 0.55% 0.50% 0.55% Recovery (%) Au % 93.7% 95.3% 96.4% 94.6% 95.8% 93.3% Recovery (%) Cu % 95.3% 95.1% 94.7% 94.1% 95.1% 94.9% Metal in Conc & Doré Prod Au oz 21,661 41,702 51,371 139,123 45,735 32,375 Metal in Conc Prod Cu T 565 580 435 2,235 518 697 Metal in Conc Prod Ag oz 26,754 37,613 41,992 142,063 34,085 42,824 Gold Equivalent Production oz 24,347 44,304 53,401 149,515 47,817 34,816 Notes – Gold equivalent for Q2 2025 is calculated based on: gold $3,299 per ounce; silver $33.41 per ounce; and copper $4.31 per pound. Gold equivalent for Q1 2025 is calculated based on: gold $2,855 per ounce; silver $31.73 per ounce; and copper $4.26 per pound Gold equivalent for Q4 2024 is calculated based on: gold $2,658 per ounce; silver $31.52 per ounce; and copper $4.25 per pound. Gold equivalent for Q3 2024 is calculated based on: gold $2,474 per ounce; silver $29.43 per ounce; and copper $4.17 per pound. Gold equivalent for Q2 2024 is calculated based on: gold $2,338 per ounce; silver $28.84 per ounce; and copper $4.42 per pound. Qualified Person K92 Mine Chief Geologist, Andrew Kohler, PGeo, a qualified person under the meaning of Canadian National Instrument 43-101 – Standards of Disclosure for Mineral Projects , has reviewed and is responsible for the technical content of this news release. Data verification by Mr. Kohler includes significant time onsite reviewing drill core, face sampling, underground workings, and discussing work programs and results with geology and mining personnel. Technical Report The Updated DFS and mineral resource estimate for the Kainantu Gold Mine Project in Papua New Guinea is presented in a technical report, titled, 'Independent Technical Report, Kainantu Gold Mine, Updated Definitive Feasibility Study, Kainantu Project, Papua New Guinea' dated March 21, 2025, with an effective date of January 1, 2024. About K92 K92 Mining Inc. is engaged in the production of gold, copper and silver at the Kainantu Gold Mine in the Eastern Highlands province of Papua New Guinea, as well as exploration and development of mineral deposits in the immediate vicinity of the mine. The Company declared commercial production from Kainantu in February 2018, is in a strong financial position, and is working to become a Tier 1 mid-tier producer through ongoing plant expansions. A maiden resource estimate on the Blue Lake copper-gold porphyry project was completed in August 2022. K92 is operated by a team of mining company professionals with extensive international mine-building and operational experience. On Behalf of the Company, John Lewins, Chief Executive Officer and Director For further information, please contact David Medilek, CFA, President and Chief Operating Officer at +1-604-416-4445 CAUTIONARY STATEMENT REGARDING FORWARD-LOOKING INFORMATION: This news release includes certain 'forward-looking statements' under applicable Canadian securities legislation. Such forward-looking statements include, without limitation: (i) the results of the Kainantu Mine Definitive Feasibility Study, including the Stage 3 Expansion, a new standalone 1.2 million tonnes per annum process plant and supporting infrastructure; (ii) statements regarding the expansion of the mine and development of any of the deposits; (iii) the Kainantu Stage 4 Expansion, operating two standalone process plants, larger surface infrastructure and mining throughputs; and (iv) the potential extended life of the Kainantu Mine. All statements in this news release that address events or developments that we expect to occur in the future are forward-looking statements. Forward-looking statements are statements that are not historical facts and are generally, although not always, identified by words such as 'expect', 'plan', 'anticipate', 'project', 'target', 'potential', 'schedule', 'forecast', 'budget', 'estimate', 'intend' or 'believe' and similar expressions or their negative connotations, or that events or conditions 'will', 'would', 'may', 'could', 'should' or 'might' occur. All such forward-looking statements are based on the opinions and estimates of management as of the date such statements are made. Forward-looking statements are necessarily based on estimates and assumptions that are inherently subject to known and unknown risks, uncertainties and other factors, many of which are beyond our ability to control, that may cause our actual results, level of activity, performance or achievements to be materially different from those expressed or implied by such forward-looking information. Such factors include, without limitation, Public Health Crises, including the epidemic or pandemic viruses; changes in the price of gold, silver, copper and other metals in the world markets; fluctuations in the price and availability of infrastructure and energy and other commodities; fluctuations in foreign currency exchange rates; volatility in price of our common shares; inherent risks associated with the mining industry, including problems related to weather and climate in remote areas in which certain of the Company's operations are located; failure to achieve production, cost and other estimates; risks and uncertainties associated with exploration and development; uncertainties relating to estimates of mineral resources including uncertainty that mineral resources may never be converted into mineral reserves; the Company's ability to carry on current and future operations, including development and exploration activities at the Arakompa, Kora, Judd and other projects; the timing, extent, duration and economic viability of such operations, including any mineral resources or reserves identified thereby; the accuracy and reliability of estimates, projections, forecasts, studies and assessments; the Company's ability to meet or achieve estimates, projections and forecasts; the availability and cost of inputs; the availability and costs of achieving the Stage 3 Expansion or the Stage 4 Expansion; the ability of the Company to achieve the inputs the price and market for outputs, including gold, silver and copper; failures of information systems or information security threats; political, economic and other risks associated with the Company's foreign operations; geopolitical events and other uncertainties, such as the conflicts in Ukraine, Israel and Palestine; compliance with various laws and regulatory requirements to which the Company is subject to, including taxation; the ability to obtain timely financing on reasonable terms when required; the current and future social, economic and political conditions, including relationship with the communities in Papua New Guinea and other jurisdictions it operates; other assumptions and factors generally associated with the mining industry; and the risks, uncertainties and other factors referred to in the Company's Annual Information Form under the heading 'Risk Factors'. Estimates of mineral resources are also forward-looking statements because they constitute projections, based on certain estimates and assumptions, regarding the amount of minerals that may be encountered in the future and/or the anticipated economics of production. The estimation of mineral resources and mineral reserves is inherently uncertain and involves subjective judgments about many relevant factors. Mineral resources that are not mineral reserves do not have demonstrated economic viability. The accuracy of any such estimates is a function of the quantity and quality of available data, and of the assumptions made and judgments used in engineering and geological interpretation, Forward-looking statements are not a guarantee of future performance, and actual results and future events could materially differ from those anticipated in such statements. Although we have attempted to identify important factors that could cause actual results to differ materially from those contained in the forward-looking statements, there may be other factors that cause actual results to differ materially from those that are anticipated, estimated, or intended. There can be no assurance that such statements will prove to be accurate, as actual results and future events could differ materially from those anticipated in such statements. Accordingly, readers should not place undue reliance on forward-looking statements. The Company disclaims any intention or obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, except as required by law. Figure 1: Quarterly Production, Co-Product Cash Cost and Co-Product AISC Chart Figure 2: Gold and Copper Recoveries Chart Photos accompanying this announcement are available athttps:// Disclaimer: The above press release comes to you under an arrangement with GlobeNewswire. Business Upturn takes no editorial responsibility for the same. Ahmedabad Plane Crash GlobeNewswire provides press release distribution services globally, with substantial operations in North America and Europe.
